Doxorubicin and Topotecan for Relapsed/Refractory Small Cell Lung Cancer (SCLC): A FPBCC Clinical Trials Network Phase I Study

被引：0
|
作者：
Umakanthan, J. Manikkam [1 ]
Marr, A. [1 ]
Ernani, V. [1 ]
Kessinger, M. [1 ]
Smith, L. [2 ]
Tijerina, J. [1 ]
Radniecki, S. [1 ]
Kosmacek, E. [1 ]
Ketcham, M. [1 ]
Ganti, A. K. [3 ,4 ]
机构：
[1] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Div Hematol & Oncol, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA
[3] Va Nebraska Western Iowa Hlth Care Syst, Div Hematol & Oncol, Omaha, NE USA
[4] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
small cell lung cancer; topotecan; Doxorubicin;
D O I：
10.1016/j.jtho.2017.09.1406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.15-013
引用
收藏
页码：S2188 / S2188
页数：1
相关论文
共 50 条
  • [21] Topotecan for relapsed small cell lung cancer: retrospective study
    Alegria, Ana M.
    Rodrigues, Cidalia
    Teixeira, Encarnacao
    Barata, Fernando
    Sotto-Mayor, Renato
    Figueiredo, Ana
    Rito, Emilia
    Almeida, Antonio B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S805 - S805
  • [22] NGR-HTNF PLUS DOXORUBICIN IN RELAPSED SMALL CELL LUNG CANCER (SCLC)
    Novello, Silvia
    Cavina, Raffaele
    Vigano, Maria G.
    Grossi, Francesco
    Santoro, Armando
    Gregorc, Vanesa
    Scagliotti, Giorgio
    Garassino, Isabella
    Rossoni, Gilda
    Levra, Matteo G.
    Genova, Carlo
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1348 - S1349
  • [23] NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)
    Cavina, Raffaele
    Gregorc, Vanesa
    Novello, Silvia
    Grossi, Francesco
    Santoro, Armando
    Vigano, Maria Grazia
    Levra, Matteo G.
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Cisplatin-topotecan-paclitaxel weekly administration in ovarian (OC) and small cell lung cancer (SCLC). A phase I study
    Frasci, G
    Comella, P
    Carteni, G
    Panza, N
    Guida, T
    Nicolella, GP
    Lombardi, R
    Pacilio, C
    Gravina, A
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 70
  • [25] Phase I Study of Topotecan and Cisplatin in Patients with Small Cell Lung Cancer
    Ichinose, Yukito
    Seto, Takashi
    Nishiwaki, Yutaka
    Kiura, Katsuyuki
    Sakai, Hiroshi
    Yokoyama, Akira
    Segawa, Yoshihiko
    Ando, Masahiro
    Watanabe, Koshiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 197 - 203
  • [26] Epirubicin combined with ifosfamide in relapsed or refractory small cell lung cancer (SCLC) patients
    Jacot, William
    Molinier, Olivier
    Colinet, Benoit
    Bozonnat, Marie-Cecile
    Quantin, Xavier
    Gervais, Radj
    Pujol, Jean-Louis
    ANNALS OF ONCOLOGY, 2006, 17 : 232 - 233
  • [27] Phase II study of weekly cisplatin, etoposide and irinotecan (PE/CPT) for refractory relapsed small cell lung cancer (SCLC).
    Kim, Y.
    Goto, K.
    Nishiwaki, Y.
    Kubota, K.
    Omatsu, H.
    Tamura, T.
    Ohe, Y.
    Kunitoh, H.
    Sekine, I.
    Yamamoto, N.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 386S - 386S
  • [28] Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer.
    Bhattacharyya, Gouri Shankar
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Bondarde, Shailesh A.
    Malhotra, Hemant
    Vora, Amish
    Govindbabu, K.
    Ranade, Anantbhushan A. B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S743 - S743
  • [29] Topotecan is an effective treatment for small cell lung cancer (SCLC) in clinical routine use
    Fink, T
    Kaubitzsch, S
    Ficker, J
    LUNG CANCER, 2005, 49 : S318 - S318
  • [30] Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
    Francesco Gelsomino
    Marcello Tiseo
    Fausto Barbieri
    Ferdinando Riccardi
    Luigi Cavanna
    Antonio Frassoldati
    Angelo Delmonte
    Lucia Longo
    Claudio Dazzi
    Saverio Cinieri
    Ida Colantonio
    Francesca Sperandi
    Giuseppe Lamberti
    Stefano Brocchi
    Lorenzo Tofani
    Luca Boni
    Andrea Ardizzoni
    British Journal of Cancer, 2020, 123 : 26 - 32
12345